Evidence map›Paper›PMID 29983147›Full record

ReviewInterventional cardiology clinics2018

Myocardial Viability Testing to Guide Coronary Revascularization.

Adrián I Löffler, Christopher M Kramer

Abstract readReview
In one paragraph

Review in Interventional cardiology clinics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Association of total Q/R ratio with myocardial scar in patients with chronic total occlusion.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Cardiac Magnetic Resonance Imaging in Heart Failure.Cardiovascular innovations and applications · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Validity of resting strain/strain rate in prediction of myocardial viability.The international journal of cardiovascular imaging · 2022
    Article
  17. Article
  18. Article
  19. Multimodality Imaging of Myocardial Viability.Current cardiology reports · 2021
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adrián I LöfflerDivision of Cardiovascular Medicine, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA.
Christopher M KramerDivision of Cardiovascular Medicine, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA; Department of Radiology and Medical Imaging, Cardiovascular Imaging Center, University of Virginia Health System, Box 800170, 1215 Lee Street, Charlottesville, VA 22908, USA. Electronic address: ckramer@virginia.edu.

Funding

Training in Cardiovascular Imaging ResearchT32EB003841 · NIBIB · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jonathan R Lindner · 2004 to 2026
$4.4M
NIBIB NIH HHS T32 EB003841
6 · The paper itself

Abstract

Left ventricular dysfunction remains one of the best prognostic determinants of survival in patients with coronary artery disease. Revascularization has been shown to improve survival compared with medical therapy alone. Viability testing can help direct patients who will benefit the most from revascularization. Single-photon emission computed tomography, dobutamine stress echo, cardiac MRI, and PET imaging with F18-fluorodeoxyglucose are the most common modalities for assessing myocardial viability. Viability testing can help differentiate which patients benefit most from chronic total occlusion interventions.

Indexed as

Chronic DiseaseCoronary OcclusionEchocardiography, StressFluorodeoxyglucose F18Heart FailureHumansMagnetic Resonance AngiographyMyocardial RevascularizationMyocardial StunningPositron-Emission TomographyRadiopharmaceuticalsTissue SurvivalTomography, Emission-Computed, Single-PhotonVentricular Dysfunction, LeftFluorodeoxyglucose F18RadiopharmaceuticalsChronic total occlusionHibernationRevascularizationViability

Identifiers

PMID29983147
PMCPMC6044453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.